Zidovudine therapy protects against Salmonella bacteremia recurrence in human immunodeficiency virus-infected patients

Journal of Infectious Diseases

Volumn 179, Issue 6, 1999, Pages 1553-1556

  Casado, Jose L ^a   Valdezate, Silvia ^a   Calderon, Celia ^a   Navas, Enrique ^a   Frutos, Begoña ^a   Guerrero, Antonio ^a   Martinez Beltran, Jesús ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; COTRIMOXAZOLE; ZIDOVUDINE;

ADULT; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; FEMALE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT INFECTION; SALMONELLA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AMOXICILLIN; ANTI-HIV AGENTS; ANTI-INFECTIVE AGENTS; BACTEREMIA; CIPROFLOXACIN; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROBABILITY; RECURRENCE; SALMONELLA INFECTIONS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; ZIDOVUDINE;

EID: 0033033034     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314749     Document Type: Article

References (14)

1. 1. Nadelman RB, Mathur-Wagh U, Yancovitz SR, Mildvan D. Salmonella bacteremia associated with acquired immunodeficiency syndrome (AIDS). Arch Intern Med 1985;145:1968-71.
2. 2. Glaser JB, Morton-Kute L, Berger SR, et al. Recurrent Salmonella typhimurium bacteremia associated with the acquired immunodeficiency syndrome. Ann Intern Med 1985;102:189-93.
3. 3. Sperber SJ, Schleupner CJ. Salmonellosis during infection with human immunodeficiency virus. Rev Infect Dis 1987;9:925-34.
4. 4. Jacobs JL, Gold JWM, Murray HW, Roberts RB, Armstrong D. Salmonella infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1985;102:186-8.
5. 5. Elwell LP, Ferone R, Freeman GA, et al. Antibacterial activity and mechanisms of action of 3′-azido-3′ deoxythymidine (BW A509U). Antimicrob Agents Chemother 1987;31:274-80.
6. 6. Lewis CS, Amyes SGB. Conditions required for the antibacterial activity of the zidovudine. Eur J Clin Microbiol Infect Dis 1989;8:737-41.
7. 7. Farmer JJ III, Kelly MT. Enterobacteriaccac. In: Balows A, Hausler WJ Jr, Hermann KL, Isenberg HD, Shadomy HJ, eds. Manual of clinical microbiology, 5th ed. Washington, DC: American Society for Microbiology, 1990:360-83.
8. 8. Sanchez Carrillo C, Menasalvas A, Cotarelo M, Diaz MD, Cercenado E, Bouza E. In vitro activity of antiviral agents used in AIDS against Salmonella typhi and non-typhoid salmonella. J Antimicrob Chemother 1996;38:153-4.
9. 9. National Committee for Clinical Laboratory Standards. Document M7-A3. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. 3rd ed. Approved standard NCCLS. Villanova, PA: NCCLS, 1993;13:25.
10. 10. Lewis CS, Allen R, Amyes SGB. Zidovudine resistance in Salmonella typhimurium and Escherichia coli. J Antimicrob Chemother 1990;25:706-8.
11. 11. Smith PD, Macher AM, Bookman MA, et al. Salmonella typhimurium enteritis and bacteremia in the acquired immunodeficiency syndrome. Ann Intern Med 1985;102:207-9.
12. 12. Fischl M, Dickinson GM, Sinave C, Pitchenik AE, Cleary TJ. Salmonella bacteremia as manifestation of acquired immunodeficiency syndrome. Arch Intern Med 1986;146:113-5.
13. 13. Salmon D, Detruchis P, Leport C, et al. Efficacy of zidovudine in preventing relapses of Salmonella bacteremia in AIDS. J Infect Dis 1991;163:415-6.
14. 14. Tumbarello M, Tacconelli E, Cauda R, Ortona L. Role of trimethoprimsulphamethoxazole in preventing HIV-associated bacteracmia. AIDS 1997;11:1070-1.